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Salivary gland tumors constitute a highly heterogeneous histopathologic group. There are few epidemiological studies
of large series of benign and malignant salivary gland tumors in Brazil.
MATERIAL AND METHODS: Hospital records of 124 patients with salivary gland tumors diagnosed from January
1993 to December 1999 were reviewed. The patients were analyzed according to gender, age, size, location, and
histopathology of the tumor.
RESULTS AND CONCLUSIONS: Patients with benign and malignant tumors presented with a mean age of 47.7 and
48.8 years, respectively. The frequency of benign tumors was 80% (n = 99) and malignant tumors 20% (n = 25). Tumors were
localized in the parotid gland 71% (n = 88), in the submandibular gland 24% (n = 30), and in the minor salivary glands 5%
(n = 6). The most common benign tumors were pleomorphic adenoma in 84% (n = 84) and Warthin’s tumor in 13% (n = 13).
Among malignant tumors, mucoepidermoid carcinoma was the most common in 52% (n = 13), adenoid cystic carcinoma
occurred in 20% (n = 5), and carcinoma ex pleomorphic adenoma was detected in 12% (n = 3).
DESCRIPTORS: Salivary gland tumors. Brazilian epidemiology.
INTRODUCTION
Salivary gland tumors are uncom-
mon, corresponding to approximately
3% to 10% of neoplasms of the head
and neck region1,2. Incidence rates of
malignant salivary gland tumors range
from 0.5 to 1.2 cases per 100,000 in-
habitants per year3,4. These tumors oc-
cur mainly in the parotid gland, but
the submandibular gland, minor sali-
vary gland (15% of all salivary gland
neoplasms), and sublingual gland can
be affected too1. There are few epide-
miological studies of large series of be-
nign and malignant salivary gland
tumors in Brazil. The goal of this
study was to retrospectively analyze
99 benign and 25 malignant primary
epithelial tumors of the major and mi-
nor salivary glands, regarding age,
gender, tumor location, tumor size,
and histological type of these lesions
in Brazilian patients.
MATERIAL AND METHODS
The data were collected from 1993
to 1999 from the files of our division.
We found during this period 124
tumors of the salivary glands, 99 be-
ing benign and 25 malignant. Informa-
tion about age, gender, tumor location,
and tumor size was obtained from each
clinical record. The histopathological
analysis of all cases was meticulously
reviewed and classified according to
the Armed Forces Institute of Pathol-
ogy5 (AFIP) by 3 expert pathologists.
RESULTS
Patients with benign and malignant
tumors presented with a mean age of
47.7 and 48.8 years, respectively. The
distributions of age, gender, tumor lo-
cation, size, and histopathological di-
agnosis are shown in tables 1, 2, 3, 4,
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and 5. No case of salivary gland tumor
was noted in the sublingual gland.
BENIGN  TUMORS
Pleomorphic Adenoma
Eighty-four tumors were diagnosed
as pleomorphic adenoma (PA), which
corresponded to 59% of all tumors of
our sample. The parotid gland was af-
fected in 58 cases, followed by 24 and
2 cases in submandibular and minor
salivary glands, respectively. The fe-
male-to-male ratio was 2:1. The age
range was 13-84 years. The mean age
for both groups (female and male) was
39 years of age. The average size
(maximum diameter) was 3.12 cm
(range 0.5-10 cm). Seven out of 84 PA
recurred.
Warthin’s Tumor
Thirteen patients in our study
(10.5%) had Warthin’s tumor. Warthin’s
tumors affected only the parotid gland,
and were bilateral in 1 case. This
tumor occurred in 10 males and 3 fe-
males. The age range was 43-73 years.
The mean age for both groups (female
and male) was 59 years of age. The av-
erage size (maximum diameter) was
4.15 cm (range, 1.5-7.5 cm).
Basal Cell Adenoma
One basal cell adenoma case was
diagnosed in the parotid gland of a
man of 44 years of age. This tumor
was 2.20 cm at the maximum diameter.
Myoepithelioma
One myoepithelioma was detected
Table 1 - Age and gender of patients with 99 benign and 25 malignant primary epithelial salivary gland tumors.
Tumors Gender Age (years) Age range (years)
Male Female
Benign
 Pleomorphic adenoma 29 (34.52%) 55 (65.48%) 39.00 13-84
 Warthin’s tumor 10 (76.92%) 3 (23.08%) 59.00 43-73
 Basal cell adenoma 1 (100.00%) 0 44.00 _____
 Myoepithelioma 0 1 (100.00%) 49.00 _____
Malignant
 Mucoepidermoid carcinoma 5 (38.46%) 8 (61.54%) 37.92 17-76
 Adenoid cystic carcinoma 2 (40.00%) 3 (60.00%) 55.20 35-77
 Carcinoma ex pleomorphic adenoma 0 3 (100.00%) 51.00 30-73
 Acinic cell carcinoma 1 (100.00%) 0 36.00 _____
 Adenocarcinoma NOS 0 1 (100.00%) 48.00 _____
 Epithelial-myoepithelial carcinoma 1 (100.00%) 0 73.00 _____
 Papillary cystadenocarcinoma 1 (100.00%) 0 41.00 _____
Table 2 - Location of 99 benign salivary gland tumors.
Parotid gland Submandibular gland  Minor salivary gland Total n
n % n % n %
Pleomorphic adenoma 58 69.05 24 28.57 2 2.38 84
Warthin’s tumor 13 100 0 0.00 0 0.00 13
Basal cell adenoma 1 100 0 0.00 0 0.00 1
Myoepithelioma 1 100 0 0.00 0 0.00 1
Total 73 73.73 24 24.24 2 2.02 99
Table 3 - Location of 25 malignant salivary gland tumors.
Parotid gland Submandibular gland  Minor salivary gland Total n
n % n % n %
Mucoepidermoid carcinoma 9 69.2 1 7.69 3 23.0 13
Adenoid cystic carcinoma 0 0.00 4 80.0 1 20.0 5
Carcinoma ex pleomorphic adenoma 3 100 0 0.00 0 0.00 3
Acinic cell carcinoma 1 100 0 0.00 0 0.00 1
Adenocarcinoma NOS 0 0.00 1 100 0 0.00 1
Epithelial-myoepithelial carcinoma 1 100 0 0.00 0 0.00 1
Papillary cystadenocarcinoma 1 100 0 0.00 0 0.00 1
Total 15 60.0 6 24.0 4 16.0 25
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in the parotid gland of a woman of 49
years of age. This tumor was a 2.00 cm
at the maximum diameter.
MALIGNANT  TUMORS
Mucoepidermoid Carcinoma
Thirteen tumors were detected as
mucoepidermoid carcinoma, and these
accounted for 10.5% of all cases or
52% of the malignant tumors. We
noted 9, 3, and 1 case in the parotid,
minor salivary, and submandibular
glands, respectively. Seven cases were
histologically classified as low grade
(5 cases located in the parotid gland
and 2 cases in the minor salivary
gland), 2 cases as intermediate grade
(2 cases located in the parotid gland),
and 4 cases as high grade of malig-
nancy (2 cases in the parotid gland and
1 case each in the submandibular and
minor salivary glands). Muco-
epidermoid carcinoma occurred in
8 females and 5 males, with an age
range of 17-76 years. The mean age for
both groups (female and male) was
37.92 years. The average size (maxi-
mum diameter) was 3.06 cm (range,
1.0-6.0 cm).
Adenoid Cystic Carcinoma
Five tumors were histopathologi-
cally diagnosed as adenoid cystic car-
cinoma (ACC), and these accounted for
4% of all cases or 20% of the malig-
nant tumors. We observed 4 cases of
ACC in the submandibular gland and
1 in the minor salivary gland. The pre-
dominant histological subtype of ACC
was cribriform (3 cases located in the
submandibular gland) followed by a
solid variant (1 case located in the
submandibular gland and another in
the minor salivary gland). ACC af-
fected 3 females and 2 males. The age
range was 35-77 years. The mean age
for both groups (female and male) was
55.2 years. The average size (maxi-
mum diameter) was 4.10 cm (range,
3.0-5.8 cm).
Carcinoma ex Pleomorphic Ad-
enoma
Three cases were diagnosed as car-
cinoma ex pleomorphic adenoma
(CPA) and these accounted for 2.4% of
all tumors or 12% of the malignant sali-
vary gland tumors. We detected 3 cases
of CPA only in the parotid gland. The
malignant component noted in all
cases was adenocarcinoma. CPA af-
fected only women in our study popu-
lation. The age range was 30-73 years.
The peak incidence was in the 5th dec-
ade. The average size (maximum diam-
eter) was 3.50 cm (range, 1.5-4.5 cm).
Acinic Cell Carcinoma
One acinic cell carcinoma case was
diagnosed in the parotid gland of a
man of 36 years of age. This tumor
had a maximum diameter of 2.00 cm.
Adenocarcinoma not otherwise speci-
fied (NOS) low grade
One adenocarcinoma NOS case
was observed in the submandibular
gland of a woman of 48 years of age.





noma was identified in the parotid
Table 4 - Size of benign and malignant tumors of salivary gland.
Tumors Average size (cm) Minimum and
Maximum diameter (cm)
Benign
 Pleomorphic adenoma 3.12 0.5-10
 Warthin’s tumor 4.15 1.5-7.5
 Basal cell adenoma 2.20 _____
 Myoepithelioma 2.00 _____
Malignant
 Mucoepidermoid carcinoma 3.06 1.0-6.0
 Adenoid cystic carcinoma 4.10 3.0-5.8
 Carcinoma ex pleomorphic adenoma 3.50 1.5-4.5
 Acinic cell carcinoma 2.00 _____
 Adenocarcinoma NOS 1.20 _____
 Epithelial-myoepithelial carcinoma 6.00 _____
 Papillary cystadenocarcinoma 4.50 _____
Table 5 - Histopathological diagnosis of 99 benign and 25 malignant salivary
gland tumors.
Histological type n % for group
Benign
Pleomorphic adenoma 84 84.84
Warthin’s tumor 13 13.13
Basal cell adenoma 1 1.01
Myoepithelioma 1 1.01
Malignant
Mucoepidermoid carcinoma 13 52.00
Adenoid cystic carcinoma 5 20.00
Carcinoma ex pleomorphic adenoma 3 12.00
Acinic cell carcinoma 1 4.00
Adenocarcinoma NOS 1 4.00
Epithelial-myoepithelial carcinoma 1 4.00
Papillary cystadenocarcinoma 1 4.00
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gland of a man of 73 years of age. This




was noted in the parotid gland of a
man of 41 years of age. This tumor
had a maximum diameter of 4.50 cm.
DISCUSSION
In this present study, we reviewed
124 major and minor salivary gland
tumors, revealing a predominance of
benign (80%) compared to malignant
tumors (20%). The vast majority of our
salivary gland tumors occurred in a
major salivary gland (95%), especially
in the parotid gland. We found a higher
prevalence of salivary gland tumors in
females (60%) than in males (40%).
The peak incidence was in the 4th dec-
ade. In contrast, Frade Gonzalez et al.4
observed a predominance of salivary
gland tumors in the male group
(58.75%) and in the 7th decade of age.
We found in the English literature
a predominance of benign salivary
gland tumors (60% to 80%) compared
with malignant tumors (20% to 40%),
which is similar to our findings. Satko
et al.6, analyzing a group of 1021
Slovakian patients with salivary gland
tumors, observed that the frequency of
benign tumors (74%) was higher than
that of malignant tumors (26%).
Ma’aita et al.7 analyzing 221 salivary
gland tumors in a Jordanian popula-
tion, found 151 benign and 70 malig-
nant tumors. Osuch-Wojcikiewicz et
al.8, studying 332 Polish patients with
salivary gland tumors, reported 275
benign and 57 malignant tumors. In
contrast, Bardwill et al.9 and Lopes et
al.10 reported a higher prevalence of
malignant tumors in minor salivary
glands. However, as these data were
collected from cancer centers9,10, a cer-
tain degree of bias must be considered.
In our opinion, it is more appropriated
to consider the prevalence of benign
and malignant tumors of minor sali-
vary glands as similar. We detected in
our sample 16.9% major and 3.22%
minor salivary gland tumors that were
malignant; however, when we consid-
ered only tumors occurring in the mi-
nor salivary glands, malignant tumors
were more prevalent, representing 4
out of 6 or 66.6% of tumors.
 No case of salivary gland tumor
was noted in the sublingual gland in
our study. This result demonstrates the
low prevalence of sublingual tumors,
as has been reported by Eveson et al.1,
who observed 1 sublingual tumor to
100 parotid tumors. Similarly, Ma’aita
et al.7 reported 1 sublingual tumor
(0.4%) among 221 cases. In contrast,
Satko et al.6 reported sublingual
tumors in 33 out of 1021 salivary
gland tumors, which presented a
higher incidence (3.2%) than that of
minor salivary gland tumors (3%).
Pleomorphic adenoma was the
most common tumor (67.7%) of all sali-
vary glands in the present study and
corresponded to 84.8% of all benign
tumors. Eighty-two cases occurred in
major glands (58 cases in the parotid
and 24 in the submandibular gland)
compared with 2 cases in minor sali-
vary glands. All epidemiological pa-
pers analyzing the prevalence of sali-
vary gland tumors in the head and neck
region showed a singular predomi-
nance of pleomorphic adenoma (50%
to 80%) among benign and malignant
tumors4,6,8. The parotid gland is the
main site affected by pleomorphic ad-
enomas followed by the submandibu-
lar and minor salivary glands.
Warthin’s tumor (WT) comprised
13% of the benign salivary gland
tumors, but none were found in the
submandibular, sublingual, or minor
salivary glands. The frequency ob-
served in the literature of WT ranged
from 9% to 28%5,11-13. Most bilateral
parotid gland tumors are WT, but
bilateralism occurred in only 1 out of
13 cases in our study population.
Basal cell adenomas and
myoepitheliomas occurred only in the
parotid gland. Basal cell adenomas are
reported as clinical cases affecting
principally the parotid gland, and the
peak incidence has ranged from the 4th
to the 7th decade14. Myoepithelioma
represents about 1% to 1.5% of all sali-
vary gland tumors and is most fre-
quently located in the parotid gland,
as we found in our study.
Mucoepidermoid carcinomas
(MEC) were more common in major
salivary glands (8% of salivary gland
tumors) than in minor salivary glands
(2.4%). When we evaluated only ma-
lignant tumors, MEC was the most
common tumor (52%). We detected 7
low-grade cases, 2 intermediate-grade
cases, and 4 high-grade cases of ma-
lignancy. Of the 234 cases of MEC re-
ported by Goode et al.15, 178 cases
were low grade, 18 cases intermediate
grade, and 31 cases high grade of ma-
lignancy.
Adenoid cystic carcinoma (ACC)
occurred in 5 cases of the total sam-
ple, 4 cases (16% of malignant salivary
gland tumors) in the submandibular
gland, and 1 case in a minor salivary
gland (4%). Szmeja et al.16, studying
111 cases of ACC, observed that the
main site affected was the parotid
gland (47 cases), and the most common
location of ACC in a minor salivary
gland was the palate (14 cases).
Carcinoma ex pleomorphic ad-
enoma formed 12% of malignant sali-
vary gland tumors and affected only the
parotid gland in our study population.
Olsen et al.17 reported 73 cases of car-
cinoma ex pleomorphic adenoma, of
which 64% occurred in males and
36% in females. The mean age was 61
years. Adenocarcinoma (31 cases) and
salivary duct carcinoma (24 cases)
were the most common malignant
subtypes. Our 3 cases affected females
only, the peak incidence was the 5th
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decade, and the only malignant histo-
logical subtype observed was adeno-
carcinoma.
Acinic cell carcinoma, adenocarci-
noma NOS, epithelial-myoepithelial
carcinoma, and papillary cystadenocar-
cinoma occurred in 1 case each and af-
fected the major salivary glands.
CONCLUSIONS
The epidemiological analysis of
124 salivary gland tumors has permit-
ted the following conclusions:
1) Patients with benign and malignant
tumors presented with a mean age
of 47.7 and 48.8 years, respec-
tively.
2) The frequency of benign tumors
was 80% (n = 99) and of malignant
tumors was 20% (n = 25).
3) 71% (n = 88) of the tumors were lo-
calized in the parotid gland, 24%
(n = 30) in the submandibular
gland, and 5% (n = 6) in the minor
salivary glands.
4) The most common benign tumors
were pleomorphic adenoma (84%, n
= 84) and Warthin’s tumor (13%, n
= 13). Among malignant tumors,
mucoepidermoid carcinoma was the
most common (52%, n = 13) fol-
lowed by adenoid cystic carcinoma
(20%, n = 5), and carcinoma ex pleo-
morphic adenoma (12%, n = 3).
ACKNOWLEDGEMENTS
The authors thank the paramedical
staff (Jairo Marcondes Silva and Doug-
las Moreira) who provided the slides
for histopathological study and CNPq
for the financial support.
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VARGAS PA e col. - Estudo retros-
pectivo de 124 casos de tumores de
glândulas salivares em uma popu-
lação brasileira. Rev. Hosp. Clín.
Fac. Med. S. Paulo 57(6):271-276,
2002.
Tumores de glândulas salivares
apresentam características histopato-
lógicas altamente heterogêneas. Exis-
tem poucos estudos epidemiológicos
analisando um número elevado de tu-
mores de glândulas salivares benignos
e malignos no Brasil.
MATERIAL E MÉTODOS: Revi-
samos os prontuários hospitalares de
124 pacientes com tumores de glându-
las salivares durante o período de Ja-
neiro de 1993 até Dezembro de 1999.
Os pacientes foram analisados de acor-
do com o sexo, idade, tamanho do tu-
mor, localização e tipo histopato-
lógico.
RESULTADOS E CONCLUSÕES:
Pacientes com tumores benignos e ma-
lignos apresentaram uma média de ida-
de de 47,7 e 48,8 anos, respectivamen-
te. A freqüência de ocorrência dos tu-
mores benignos foi de 80% (n=99) e
dos tumores malignos de 20% (n=25).
Tumores foram localizados na parótida
em 71% (n=88) dos casos, na glândula
submandibular em 24% (n=30), e glân-
dulas salivares menores em 5% (n=6).
Os principais tumores benignos foram
o Adenoma Pleomórfico que represen-
tou 84% (n=84) dos casos e o Tumor
de Warthin com 13% (n=13) dos casos.
Entre os tumores malignos, o Carcino-
ma Mucoepidermóide foi o mais co-
mum correspondendo a 52% dos casos
(n=13), seguido pelo Carcinoma
Adenóide Cístico em 20% (n=5) e Car-
cinoma ex Adenoma Pleomórfico que
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